FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells. - Test2 - elhamkhani - TriplyDB

FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.

FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.

http://www.wikidata.org/entity/Q33767083

about

FOXD3 regulates migration properties and Rnd3 expression in melanoma cells Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy Targeting TBK1 inhibits migration and resistance to MEK inhibitors in mutant NRAS melanoma.FOXD3 regulates anaplastic thyroid cancer progression.The MAPK pathway as an apoptosis enhancer in melanoma.Effects and interactions of MiR-577 and TSGA10 in regulating esophageal squamous cell carcinoma.CtBP2 downregulation during neural crest specification induces expression of Mitf and REST, resulting in melanocyte differentiation and sympathoadrenal lineage suppression.Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas Adaptive upregulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cells PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma GSK3β inhibition blocks melanoma cell/host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation.RAC1 P29S regulates PD-L1 expression in melanoma.SHOC2 and CRAF mediate ERK1/2 reactivation in mutant NRAS-mediated resistance to RAF inhibitor.Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization.Dynamic DNA methylation across diverse human cell lines and tissues MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS Melanoma.Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3 FOXD3 Promotes PAX3 Expression in Melanoma Cells Selective RAF inhibitor impairs ERK1/2 phosphorylation and growth in mutant NRAS, vemurafenib-resistant melanoma cells.JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma Genetic variation in phosphodiesterase (PDE) 7B in chronic lymphocytic leukemia: overview of genetic variants of cyclic nucleotide PDEs in human disease.In vivo MAPK reporting reveals the heterogeneity in tumoral selection of resistance to RAF inhibitors.Down-regulation of long non-coding RNA FOXD3 antisense RNA 1 (FOXD3-AS1) inhibits cell proliferation, migration, and invasion in malignant glioma cells.FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma.Downregulation of the transcription factor, FoxD3, is associated with lymph node metastases in invasive ductal carcinomas of the breast.Resistance to RAF inhibitors revisited.FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway.Mining for novel tumor suppressor genes using a shortest path approach.FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer.Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3/miR-143 axis.Tanapoxvirus lacking a neuregulin-like gene regresses human melanoma tumors in nude mice.Crosstalk signaling in targeted melanoma therapy.Foxd3 suppresses interleukin-10 expression in B cells.BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer MITF depletion elevates expression levels of ERBB3 receptor and its cognate ligand NRG1-beta in melanoma.FOXD3 modulates migration through direct transcriptional repression of TWIST1 in melanoma.Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011".ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma.Transcription factors as critical players in melanoma invasiveness, drug resistance, and opportunities for therapeutic drug development.

P2860

Q24633339-03F376D4-2574-4C7C-B475-D56AA59B77F4 Q26783032-8F5FFD03-ECFC-4413-A08C-C77905DF6995 Q27853026-E5AB0159-44E8-48BE-9609-AA72AD512D4F Q33779603-9627B86D-2BB2-45CF-8CE0-9D68C0DB1B65 Q34104135-97227A7A-CEA1-4620-8E65-0ED1102550E0 Q34389137-30245AFD-4C32-4D9D-A65F-C95DD4BE439C Q34742221-81DE368F-9305-48AC-B320-CDA44977FF21 Q34786402-AAF4C1E9-56FA-4BCA-BC81-FF22A7FB43D8 Q35642026-1CF3CE88-D397-4459-908A-FDFF87E02944 Q35683271-72EB9E64-F80A-4BAF-90F9-7ABC863DE54D Q36065213-4B21B8FC-6FD6-4258-AF77-4321B999A61B Q36341898-54E14824-A62A-4357-B96C-85AAD60996DE Q36362336-2E8907C0-50DD-4ECE-BB5E-8A419F29EDF2 Q36451902-26A7121F-905E-4F40-A210-DCFF759B3B0B Q36468749-5BDE6B0D-E587-40D2-8FEF-5A1A38DF46A4 Q36660155-4EDF86CB-53B7-48D6-825F-6C340681359E Q36682132-AC1D5A8A-310A-4EA2-8609-6B563FB1BC51 Q36793441-47D445CC-CFD0-4478-9AE6-2C88F3AF6167 Q36951681-C2947D0B-5199-4FEA-B35F-5AD51F3C9DCA Q36961746-F5D834E7-2529-4D5B-B2A6-22082FD65BC0 Q37233445-9359C73D-90D4-4181-BA64-59B4B8432EAD Q37323162-7C05AE8E-EE65-4D11-A03D-9858727D7657 Q37365693-6C45BC5F-3DA8-4A82-898B-189ACC083C07 Q37393397-544CEFD8-B7D1-4BE9-8AD1-921D7186D794 Q37420182-BDEACC44-9E3B-4A08-998D-6A0B39918DA3 Q37587383-E5D06757-28B8-47E2-AB09-133992415967 Q37625751-55EC076D-2145-4306-A900-B2C8A75A809F Q37706298-3DAAB796-011D-4A2E-B598-F8FCDD9B9446 Q38460190-12D3851F-2549-44C4-B0F7-C9F402C1A262 Q38603133-55E24E7F-205F-4CAD-B65A-18AFE4850B71 Q38708426-1C18B4CB-7B09-48CE-B8B6-02D591B55505 Q38741265-FE5F83B3-B297-43AB-ACFC-E327786C916A Q38757522-FF2C8E18-8B12-48B1-BCE7-F86E69B5B9A9 Q39084764-7A854F1E-63C4-4CC4-B49B-2636F6767881 Q41056167-BB35B874-590C-4A08-B7D4-13496DAA7343 Q41821510-778BB3AC-BE1A-4F68-938C-D839F27EC871 Q42546275-844264FC-B220-4073-8C5F-D4086C4D4B74 Q43215055-449A3706-960C-4A39-B595-B3E850ADCAAB Q47203970-1678D21C-3C7C-4850-B82A-DCF8558D5178 Q48090844-8A7F8180-7480-456A-A09F-59F378E13556

P2860

FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.

http://www.wikidata.org/entity/Q33767083

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.

@ast

FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.

@en

type

label

FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.

@ast

FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.

@en

prefLabel

FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.

@ast

FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.

@en

P1433

Q33767083-905C9078-9281-4004-A8C6-55C952D45222

P1476

Q33767083-4F147B05-621D-49A8-A0C9-3A85184198AD

P2093

Q33767083-29264816-C3E2-462D-8F43-720BBEA012FE

Q33767083-4BF2440E-B66F-4EF8-99EC-B1DB682CF7BB

P2860

Q33767083-02263CA4-CE62-4AB8-BA4F-EC7FC22EF4AF

Q33767083-04C07D21-272C-4707-900F-971F5924266B

Q33767083-107836FE-ACEF-4BDB-AB74-1993D0AC6871

Q33767083-165B3EC2-6CA5-43E7-8F19-7E2E1ABC99D7

Q33767083-1DE9EA5C-99B0-426D-9F5F-D9CFEB2334AE

Q33767083-23C71D41-0CAF-4C29-BA76-1AA9DE2F4047

Q33767083-278634C9-B7F1-4F00-AA64-71FA5894D487

Q33767083-2C918DE8-7A9C-4D31-BC61-7C53D62797A1

Q33767083-2F6707D9-9F17-42F4-B792-5F1E46988AEE

Q33767083-3425751C-2DF6-43D5-904B-8AE0CB0F9F08

P304

Q33767083-325D0923-1AAE-44AF-97FA-8F3ED71FD9AB

P31

Q33767083-D854AD95-59FB-4D62-AE2F-DD41392B2E82

P356

Q33767083-EF920F64-8F82-4753-A7E7-C8998C919D3A

P407

Q33767083-7EEF167F-5FB9-408D-A11E-4E39DAD9F845

P433

Q33767083-B532997A-667C-4E60-91FC-A6B7A368344A

P478

Q33767083-95EDBA25-F9D2-4028-8EDF-6C836182AAA0

P577

Q33767083-53A43E72-0EA9-4488-88D0-E1F22FF82662

P698

Q33767083-D7B45C71-04D3-4AE9-B96C-7D5ACD270D24

P932

Q33767083-01D33D4D-910D-4669-BD73-8E0DA3B51508

P356

0008-5472.CAN-09-3139

P1433

Cancer Research

P1476

FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.

@en

P2093

Andrew E Aplin

http://www.w3.org/2001/XMLSchema#string

Ethan V Abel

http://www.w3.org/2001/XMLSchema#string

P2860

The Brn-2 transcription factor links activated BRAF to melanoma proliferation

Efficient tumour formation by single human melanoma cells

Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis

Mutations of the BRAF gene in human cancer

A new mathematical model for relative quantification in real-time RT-PCR

WAF1, a potential mediator of p53 tumor suppression

The emerging roles of forkhead box (Fox) proteins in cancer

Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells

Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo

Genesis, a winged helix transcriptional repressor with expression restricted to embryonic stem cells

P304

2891-2900

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-09-3139

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20332228

http://www.w3.org/2001/XMLSchema#string

P932

2848900

http://www.w3.org/2001/XMLSchema#string